SPUTA VACUUMER®: A Paradigm Shift in Airway Clearance
Reversing the Concept: “Don’t Chase Sputum. Make it Come to You.”
Traditional suction is often painful and carries inherent risks because it requires inserting a tube deep into the airway. SPUTA VACUUMER® changes the paradigm. By applying our unique “Vacuuming” theory, we move the secretions to the catheter, rather than chasing them with a tube. This allows for safe, simple, and low-invasive airway clearance for every patient, regardless of the practitioner’s skill level.
Estimated Business Value
JPY 1.9 Billion+
Target Market
Global “Blue Ocean” in Airway Management
Disclaimer: This valuation is a conceptual estimate and is intended for reference purposes only, reflecting the technology’s potential to redefine the standard of care in the global respiratory market.
The Core Innovation
The Challenge: A Reality of Pain and Risk
Traditional suctioning inflicts severe distress, such as gagging and pain, and poses risks like mucosal damage and hypoxemia. While alternatives exist, they are often cost-prohibitive or operationally complex, leaving a critical gap in daily clinical and home care.
STONY’s Solution: The “Vacuuming” Paradigm Shift
We have developed a universal interface that converts standard suction pressure into a therapeutic “Vacuuming” force.
Universal Compatibility: Works with standard endotracheal tubes, LMAs, and suction pumps.
Low Cost / High Impact: Utilizes existing clinical infrastructure to deliver high-end results.
Safety-First Design: Eliminates the need for deep, invasive catheter insertion.
For Patients: Liberation from Pain
Transforms a traditionally “torturous” procedure into gentle, non-invasive care. It dramatically improves Quality of Life (QOL) by reducing coughing fits and mucosal trauma.
For Caregivers: Skill-Free Safety
Standardizes the technique. Even less-experienced staff or family members can perform safe suctioning, significantly reducing the burden of care and the risk of human error.
For Business: Recurring Revenue
Built on a high-volume disposable model, targeting massive, untapped markets in home care, elderly care facilities, and ICUs worldwide.
Commercial Readiness & IP Protection
1. Development Stage: Ready to Launch
- Regulatory Approved: Japan PMDA Class I (General Medical Device).
- Mass Production: High-quality production lines are established under Mother Factory Standards in Japan.
- Reliability: Precision-engineered injection molding lines are fully operational for global supply.
2. An Ironclad IP Portfolio
This system is protected not by a single patent, but by a multi-layered web of rights, making imitation extremely difficult.
- Foundational Patent: The core “Vacuuming” mechanism.
- System Patent: Protecting the clinical application and safety features.
- Global Coverage: Patents granted or pending in Japan, USA, Europe, China, and India.
Partnership Opportunity
We are seeking Global Licensing Partners to expand this new “Standard of Care” worldwide.
- India/Asia: Perfect for high-volume, cost-sensitive markets.
- US/EU: Ideal for high-value home care and infection control markets.